bms204352 has been researched along with salicylates in 1 studies
Studies (bms204352) | Trials (bms204352) | Recent Studies (post-2010) (bms204352) | Studies (salicylates) | Trials (salicylates) | Recent Studies (post-2010) (salicylates) |
---|---|---|---|---|---|
49 | 1 | 12 | 13,317 | 853 | 1,678 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Allman, BL; Dalby-Brown, W; Lobarinas, E; Mirza, NR; Salvi, R; Stolzberg, D | 1 |
1 other study(ies) available for bms204352 and salicylates
Article | Year |
---|---|
Effects of the potassium ion channel modulators BMS-204352 Maxipost and its R-enantiomer on salicylate-induced tinnitus in rats.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Indoles; Male; Polysorbates; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley; Salicylates; Surface-Active Agents; Tinnitus | 2011 |